Literature DB >> 3745010

Markedly delayed puberty or Kallmann's syndrome variant.

A Bauman.   

Abstract

A diagnosis of Kallmann's syndrome was made in a 25-year-old man. After 21 months of treatment with parenteral T, spontaneous puberty occurred at the age of 27.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3745010     DOI： 10.1002/j.1939-4640.1986.tb00918.x

Source DB:  PubMed          Journal:  J Androl        ISSN： 0196-3635


  5 in total

1.  Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia.

Authors:  Aniruthan Renukanthan; Richard Quinton; Benjamin Turner; Peter MacCallum; Leighton Seal; Andrew Davies; Richard Green; Jane Evanson; Márta Korbonits
Journal:  Endocrine       Date:  2015-03-05       Impact factor: 3.633

2.  Neurokinin B is critical for normal timing of sexual maturation but dispensable for adult reproductive function in female mice.

Authors:  Cadence True; Sayeda Nasrin Alam; Kimberly Cox; Yee-Ming Chan; Stephanie B Seminara
Journal:  Endocrinology       Date:  2015-01-09       Impact factor: 4.736

3.  Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.

Authors:  Valerie F Sidhoum; Yee-Ming Chan; Margaret F Lippincott; Ravikumar Balasubramanian; Richard Quinton; Lacey Plummer; Andrew Dwyer; Nelly Pitteloud; Frances J Hayes; Janet E Hall; Kathryn A Martin; Paul A Boepple; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

4.  A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism.

Authors:  Jia Zhu; Ruth E-Y Choa; Michael H Guo; Lacey Plummer; Cassandra Buck; Mark R Palmert; Joel N Hirschhorn; Stephanie B Seminara; Yee-Ming Chan
Journal:  J Clin Endocrinol Metab       Date:  2015-01-30       Impact factor: 5.958

5.  Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.

Authors:  Eeva-Maria Laitinen; Johanna Tommiska; Timo Sane; Kirsi Vaaralahti; Jorma Toppari; Taneli Raivio
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.